NeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call
January 20 2017 - 9:40AM
Business Wire
NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it
plans to issue its 2016 full year and fourth quarter financial
results before the opening of the market on January 26, 2017. The
Company will host a conference call at 8:00 a.m., Eastern Time on
January 26, 2017 to discuss its financial results as well as
business developments affecting the Company.
The conference call may be accessed in the United States by
dialing 844-787-0799 and using the confirmation code 49304382.
Internationally, the conference call may be accessed by dialing
661-378-9630 and using the same confirmation code. The earnings
press release and accompanying condensed financial statements will
be accessible from the Company's website at www.NeuroMetrix.com
under the "Investor Relations" tab.
A replay of the conference call will be available starting two
hours after the call by dialing 855-859-2056, domestically and
404-537-3406, internationally. The confirmation code to access the
replay is 49304382. The replay will be available for one week after
the conference call.
About NeuroMetrix
NeuroMetrix is a commercial stage, innovation driven
healthcare company combining bioelectrical and digital medicine to
address chronic health conditions including chronic pain, sleep
disorders, and diabetes. The company's lead product is Quell®, an
over-the-counter wearable therapeutic device for chronic pain.
Quell is integrated into a digital health platform that helps
patients optimize their therapy and decrease the impact of chronic
pain on their quality of life. The company also markets DPNCheck®,
a rapid point-of-care test for diabetic neuropathy, which is the
most common long-term complication of Type 2 diabetes. The company
maintains an active research effort and has several pipeline
programs, including a therapeutic device for restless leg syndrome.
The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health
Sciences and Technology in 1996. For more information, please
visit www.NeuroMetrix.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170120005334/en/
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial Officerneurometrix.ir@neurometrix.com
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Aug 2024 to Sep 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Sep 2023 to Sep 2024